Aktive Positionen von Hema Keshava
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| CINCOR PHARMA, INC. | Comptroller/Controller/Auditor | 01.11.2021 | - |
| ABIVAX | Corporate Officer/Principal | 01.07.2023 | - |
Karriereverlauf von Hema Keshava
Statistik
International
| Vereinigte Staaten | 2 |
| Frankreich | 2 |
Operativ
| Comptroller/Controller/Auditor | 1 |
| Corporate Officer/Principal | 1 |
Sektoral
| Health Technology | 3 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| ABIVAX | Health Technology |
| Private Unternehmen | 1 |
|---|---|
CinCor Pharma, Inc.
 CinCor Pharma, Inc. Pharmaceuticals: MajorHealth Technology CinCor Pharma, Inc. operates as a clinical-stage biopharmaceutical company focused on developing its clinical candidate, CIN-107, for the treatment of hypertension and other cardio-renal diseases. The firm is developing CIN-107 for the treatment of multiple diseases where aldosterone plays a significant role in disease pathophysiology, including hypertension and primary aldosteronism, as well as its utility in ameliorating complications of chronic kidney disease. The company was founded by Jon Isaacsohn and Catherine Pearce on March 28, 2018 and is headquartered in Waltham, MA. | Health Technology |
- Börse
- Insiders
- Hema Keshava
- Erfahrung
